127 related articles for article (PubMed ID: 10680707)
1. Hereditary haemorrhagic telangiectasia with protein S deficiency in a family: a case report.
Wechalekar A; Parapia L
Eur J Haematol; 2000 Jan; 64(1):59-60. PubMed ID: 10680707
[No Abstract] [Full Text] [Related]
2. [Efficacy of tranexamic acid in a patient with hereditary hemorrhagic telangiectasia and massive epistaxis].
Pérez del Molino A; Zarrabeitia R; Fernández A; Botella LM
Med Clin (Barc); 2004 Jun; 123(3):118-9. PubMed ID: 15225479
[No Abstract] [Full Text] [Related]
3. Tranexamic acid and bevacizumab in hereditary hemorrhagic telangiectasia patients presenting with epistaxis.
Lacout A; Marcy PY; El Hajjam M; Lacombe P
Cutis; 2013 Apr; 91(4):173-4. PubMed ID: 23763075
[No Abstract] [Full Text] [Related]
4. Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study.
Geisthoff UW; Seyfert UT; Kübler M; Bieg B; Plinkert PK; König J
Thromb Res; 2014 Sep; 134(3):565-71. PubMed ID: 25005464
[TBL] [Abstract][Full Text] [Related]
5. Intranasal tranexamic acid for the treatment of hereditary hemorrhagic telangiectasia: a case report and review of treatment options.
Flanagan BA; Collins C; Parra S
Cutis; 2012 Feb; 89(2):69-72. PubMed ID: 22474728
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid].
Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM
Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407
[TBL] [Abstract][Full Text] [Related]
7. Acute confusion in an elderly woman with Rendu-Osler-Weber disease.
Pollak L; Strauss S; Sanset S; Peer A; Tishler M
Isr Med Assoc J; 2006 Dec; 8(12):886-7. PubMed ID: 17214115
[No Abstract] [Full Text] [Related]
8. Subcutaneous Tranexamic Acid at the End of Life in a Patient With Hereditary Hemorrhagic Telangiectasia.
Arndt G; Wai R; Stiel H
J Palliat Med; 2024 Jun; 27(6):827-829. PubMed ID: 37768837
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cells.
Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Ramirez JR; Morales-Angulo C; Zarrabeitia R; Perez-Molino A; Bernabéu C; Botella LM
Thromb Haemost; 2007 Feb; 97(2):254-62. PubMed ID: 17264955
[TBL] [Abstract][Full Text] [Related]
10. Tranexamic acid in hereditary hemorrhagic telangiectasia.
Lozano M
N Engl J Med; 2002 Feb; 346(6):457. PubMed ID: 11832543
[No Abstract] [Full Text] [Related]
11. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
Sabbà C; Gallitelli M; Palasciano G
N Engl J Med; 2001 Sep; 345(12):926. PubMed ID: 11565536
[No Abstract] [Full Text] [Related]
12. [Pharmacological treatment of hereditary haemorrhagic telangiectasia].
Molinos-Castro S; Pesqueira-Fontán PM; Díaz-Peromingo JA
Rev Med Chil; 2009 May; 137(5):695-700. PubMed ID: 19701561
[TBL] [Abstract][Full Text] [Related]
13. Definite hereditary hemorrhagic telangiectasia in a 60-year-old black Kenyan woman: a case report.
Kiyeng JC; Siika A; Koech C; Bloomfield GS
J Med Case Rep; 2016 May; 10(1):126. PubMed ID: 27225226
[TBL] [Abstract][Full Text] [Related]
14. Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care.
Al-Samkari H
Blood; 2021 Feb; 137(7):888-895. PubMed ID: 33171488
[TBL] [Abstract][Full Text] [Related]
15. Hereditary type IIb protein S deficiency in a patient with recurrent venous ulcers.
Tsutsui K; Ishida W; Ohashi T; Takehara K
Dermatology; 1997; 194(2):198-9. PubMed ID: 9094481
[No Abstract] [Full Text] [Related]
16. Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia.
Klepfish A; Berrebi A; Schattner A
Arch Intern Med; 2001 Mar; 161(5):767. PubMed ID: 11231712
[No Abstract] [Full Text] [Related]
17. Hereditary haemorrhagic telangiectasia (HHT): negotiating between the Scylla of bleeding and Charybdis of thrombosis.
Ghosh K; Ghosh K
Thromb Haemost; 2008 Jul; 100(1):162-4. PubMed ID: 18612556
[No Abstract] [Full Text] [Related]
18. Tranexamic acid-bevacizumab synergy in HHT patients presenting pulmonary arteriovenous malformations.
Lacout A; Marcy PY; El Hajjam M; Lacombe P
Med Hypotheses; 2012 Nov; 79(5):605-6. PubMed ID: 22959314
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet and anticoagulant agents in hereditary hemorrhagic telangiectasia.
Devlin HL; Hosman AE; Shovlin CL
N Engl J Med; 2013 Feb; 368(9):876-8. PubMed ID: 23445111
[No Abstract] [Full Text] [Related]
20. Mesenteric venous thrombosis in protein S deficiency: case report and literature review.
Lau LL; McMurray AH
Ulster Med J; 1999 May; 68(1):33-5. PubMed ID: 10489811
[No Abstract] [Full Text] [Related]
[Next] [New Search]
